10/11/2026 23:07
|
Medical, Health & Aged Care
MADISON, Wis.--BUSINESS WIRE--
The U.S. Food and Drug Administration (FDA) has approved the Promega OncoMate® MSI Dx Analysis System designed to identify patients with microsatellite high (MSI-H)...